0000899243-20-026099.txt : 20200923 0000899243-20-026099.hdr.sgml : 20200923 20200923170101 ACCESSION NUMBER: 0000899243-20-026099 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200921 FILED AS OF DATE: 20200923 DATE AS OF CHANGE: 20200923 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Johnston David Michael CENTRAL INDEX KEY: 0001802057 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39212 FILM NUMBER: 201192586 MAIL ADDRESS: STREET 1: C/O PPD, INC. STREET 2: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PPD, Inc. CENTRAL INDEX KEY: 0001793294 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 453806427 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401-3331 BUSINESS PHONE: 910 251 0081 MAIL ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401-3331 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-21 0 0001793294 PPD, Inc. PPD 0001802057 Johnston David Michael C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401 0 1 0 0 See Remarks Common stock 2020-09-21 4 S 0 40000 33.11 D 53107 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.05 to $33.23, inclusive. The reporting person undertakes to provide to PPD, Inc. (the "Issuer"), any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Title: EVP of Global Clinical Development /s/ Richard Whitlow, as Attorney-in-Fact 2020-09-23